• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation.

作者信息

Katsuya Hiroo, Kizuka-Sano Haruna, Yokoo Masako, Kidoguchi Keisuke, Yamaguchi Kyosuke, Nishioka Atsujiro, Ureshino Hiroshi, Kubota Yasushi, Ando Toshihiko, Naito Shinji, Ohshima Koichi, Kimura Shinya

机构信息

Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga, 849-8501, Japan.

Department of Hematology, Saga-Ken Medical Center Koseikan, Saga, Japan.

出版信息

Ann Hematol. 2020 Oct;99(10):2449-2451. doi: 10.1007/s00277-020-04218-9. Epub 2020 Aug 26.

DOI:10.1007/s00277-020-04218-9
PMID:32851455
Abstract
摘要

相似文献

1
A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation.一种与甲氨蝶呤相关的淋巴增殖性疾病，表达CD10和BCL6，伴有IGH/CCND1易位。
Ann Hematol. 2020 Oct;99(10):2449-2451. doi: 10.1007/s00277-020-04218-9. Epub 2020 Aug 26.
2
Inferior survival in high-grade B-cell lymphoma with and and/or rearrangements is not associated with gene rearrangements.伴有 和/或 重排的高级别 B 细胞淋巴瘤患者的生存情况较差，但与 基因重排无关。
Haematologica. 2018 Nov;103(11):1899-1907. doi: 10.3324/haematol.2018.190157. Epub 2018 Jun 14.
3
Cardiac involvement of malignant lymphoma presenting intra-ventricular-wall nodules.恶性淋巴瘤累及心脏，表现为心室内壁结节。
J Echocardiogr. 2019 Dec;17(4):222-223. doi: 10.1007/s12574-018-0411-7. Epub 2018 Nov 30.
4
Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis.从滤泡性淋巴瘤进展而来并模仿获得性噬血细胞性淋巴组织细胞增生症的组织细胞肉瘤。
Ann Hematol. 2020 Oct;99(10):2441-2443. doi: 10.1007/s00277-020-04190-4. Epub 2020 Aug 17.
5
[Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].[1例伴有t(1;14)(p22;q32)及bcl-10重排的多灶性结外弥漫性大B细胞淋巴瘤经CHOP治疗后的长期缓解]
Rinsho Ketsueki. 2005 Oct;46(10):1105-8.
6
The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia.塞尔维亚东南部接受免疫化疗的弥漫性大B细胞非霍奇金淋巴瘤患者生存中Myd88 L265P突变、临床及免疫组化预后因素的重要性
J BUON. 2016 Sept-Oct;21(5):1259-1267.
7
A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.一例携带CCND1和MYC易位的“双打击”套细胞淋巴瘤，对利妥昔单抗-苯达莫司汀-阿糖胞苷（R-BAC）和伊布替尼复发/难治。
Ann Hematol. 2020 Nov;99(11):2715-2717. doi: 10.1007/s00277-020-04178-0. Epub 2020 Jul 15.
8
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.BCL-2表达及bcl-2主要断裂点区域重排在弥漫性大细胞非霍奇金淋巴瘤中的预后意义：一项英国国家淋巴瘤调查研究
Blood. 1996 Aug 1;88(3):1046-51.
9
Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中c-MYC、BCL2和BCL6基因的共存重排
Int J Hematol. 2004 Jan;79(1):52-4. doi: 10.1007/BF02983534.
10
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
Int J Hematol. 2002 Jan;75(1):107-8. doi: 10.1007/BF02981990.

引用本文的文献

1
Cyclin D2-positive mantle cell lymphoma with t(2;12)(p12;p13) arising in immune deficiency/dysregulation.免疫缺陷/失调状态下发生的伴有t(2;12)(p12;p13)的细胞周期蛋白D2阳性套细胞淋巴瘤
Ann Hematol. 2023 Sep;102(9):2639-2640. doi: 10.1007/s00277-023-05330-2. Epub 2023 Jun 23.

本文引用的文献

1
Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.其他医源性免疫缺陷相关淋巴增殖性疾病的临床管理。
J Clin Exp Hematop. 2019;59(2):72-92. doi: 10.3960/jslrt.19007.
2
CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases.CD10阳性套细胞淋巴瘤：30例临床病理及预后研究
Oncotarget. 2017 Dec 15;9(14):11441-11450. doi: 10.18632/oncotarget.23571. eCollection 2018 Feb 20.
3
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.异常表达的 CD10 和 BCL6 在套细胞淋巴瘤中。
Histopathology. 2017 Nov;71(5):769-777. doi: 10.1111/his.13286. Epub 2017 Aug 8.
4
Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis.甲氨蝶呤相关淋巴细胞增生性疾病伴T细胞大颗粒淋巴细胞增多症的自发消退
Intern Med. 2015;54(17):2235-9. doi: 10.2169/internalmedicine.54.4207. Epub 2015 Sep 1.
5
Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.单药伊布替尼治疗套细胞淋巴瘤患者的长期随访：安全性和疗效结果更新
Blood. 2015 Aug 6;126(6):739-45. doi: 10.1182/blood-2015-03-635326. Epub 2015 Jun 9.
6
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.伊布替尼治疗复发或难治性套细胞淋巴瘤中的 BTK。
N Engl J Med. 2013 Aug 8;369(6):507-16. doi: 10.1056/NEJMoa1306220. Epub 2013 Jun 19.
7
Immunophenotypic variations in mantle cell lymphoma.套细胞淋巴瘤的免疫表型变异
Am J Clin Pathol. 2009 Nov;132(5):699-706. doi: 10.1309/AJCPV8LN5ENMZOVY.
8
BCL6, MUM1, and CD10 expression in mantle cell lymphoma.套细胞淋巴瘤中BCL6、MUM1和CD10的表达情况
Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):103-8. doi: 10.1097/PAI.0b013e3181bb9edf.
9
Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis.
Nat Clin Pract Oncol. 2008 Apr;5(4):234-8. doi: 10.1038/ncponc1071. Epub 2008 Feb 19.